Total Marrow Lymphoid Irradiation/Fludarabine/ Melphalan Conditioning for Allogeneic Hematopoietic Cell Transplantation
Open Access
- 1 February 2018
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 24 (2) , 301-307
Abstract
No abstract availableKeywords
Funding Information
- Accuray Incorporated
This publication has 45 references indexed in Scilit:
- Comparable outcomes between autologous and allogeneic transplant for adult acute myeloid leukemia in first CRBone Marrow Transplantation, 2016
- Twenty years of follow‐up among survivors of childhood and young adult acute myeloid leukemiaCancer, 2008
- Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematologic disordersBlood, 2007
- Improved outcome in young adults with de novo acute myeloid leukemia in first remission, undergoing an allogeneic bone marrow transplantBone Marrow Transplantation, 2007
- Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: A Pediatric Blood and Marrow Transplant Consortium studyBone Marrow Transplantation, 2003
- Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first complete remissionBlood, 2001
- Comparison of Preparative Regimens in Transplants for Children With Acute Lymphoblastic LeukemiaJournal of Clinical Oncology, 2000
- Long-Term Follow-Up of a Randomized Trial of Two Irradiation Regimens for Patients Receiving Allogeneic Marrow Transplants During First Remission of Acute Myeloid LeukemiaBlood, 1998
- A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation GroupBlood, 1994
- Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens [see comments]Blood, 1990